---
schema_version: "secwatch.filing_event.v1"
accession: "0000950142-22-001297"
form_type: "8-K"
ticker: "VTVT"
cik: "0001641489"
company_name: "vTv Therapeutics Inc."
filed_at: "2022-04-05T23:59:59+00:00"
generated_at: "2026-06-26T09:27:39.151355+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Director Noel Spiegel will not stand for re-election at vTv Therapeutics 2022 annual meeting

## Summary
- Noel Spiegel, Audit Committee Chair, notified Company he will not stand for re-election at 2022 annual meeting.
- Decision not due to disagreement with Company's operations, policies, or practices.
- Spiegel served as director and Audit Committee Chair since IPO in 2015.

## SEC filing metadata
- accession: 0000950142-22-001297
- form_type: 8-K
- ticker: VTVT
- cik: 0001641489
- company_name: vTv Therapeutics Inc.
- filed_at: 2022-04-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641489/000095014222001297/0000950142-22-001297-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641489/000095014222001297/eh220241644_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950142-22-001297
- JSON: https://secwatch.observer/filing/0000950142-22-001297.json
- Plain text: https://secwatch.observer/filing/0000950142-22-001297.txt

## Key facts
- Executive change
  Noel Spiegel departed as Director and Chair of the Audit Committee at vTv Therapeutics Inc..
  - Action: will not stand for re-election
  - Role: Director and Chair of the Audit Committee
  source text: On March 30, 2022, Mr. Noel Spiegel, who has served as a director and Chair of the Audit Committee of the Board of vTv Therapeutics Inc. (the “Company”) since its initial public offering in 2015, notified the Company of his decision not to stand for re-election at the Company’s 2022 annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1641489/000095014222001297/0000950142-22-001297-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.